182 related articles for article (PubMed ID: 26358388)
1. Cells to Surgery Quiz: October 2015.
Aldahan AS; Mlacker S; Shah VV; Samarkandy S; Alsaidan M; Nouri K
J Invest Dermatol; 2015 Oct; 135(10):e18. PubMed ID: 26358388
[No Abstract] [Full Text] [Related]
2. Mohs micrographic surgery for the treatment of malignant melanoma.
Whalen J; Leone D
Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
[TBL] [Abstract][Full Text] [Related]
3. Mohs micrographic surgery.
Rush E
J Vis Commun Med; 2009 Jun; 32(2):49-52. PubMed ID: 20014967
[No Abstract] [Full Text] [Related]
4. Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma.
Koers K; Francken AB; Haanen JB; Woerdeman LA; van der Hage JA
J Clin Oncol; 2013 Jun; 31(16):e251-3. PubMed ID: 23569313
[No Abstract] [Full Text] [Related]
5. A Case of Giant Primary Dermal Melanoma with BRAF V600E Mutation.
Imamura T; Nakamura Y; Teramoto Y; Sato S; Asami Y; Arai E; Yamamoto A
Acta Derm Venereol; 2016 Aug; 96(6):840-1. PubMed ID: 26984828
[No Abstract] [Full Text] [Related]
6. [Skin melanoma].
Lääkäriseuran S;
Duodecim; 2005; 121(24):2725-39. PubMed ID: 16869061
[No Abstract] [Full Text] [Related]
7. Vemurafenib therapy for stage IV melanoma with V600G-mutation.
Lang N; Weisser A; Enk A; Hassel JC
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1198-9. PubMed ID: 24016000
[No Abstract] [Full Text] [Related]
8. Melanoma margins: the importance and need for more evidence-based trials.
Johnson TM; Sondak VK
Arch Dermatol; 2004 Sep; 140(9):1148-50. PubMed ID: 15381557
[No Abstract] [Full Text] [Related]
9. Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey.
Siscos SM; Neill BC; Seger EW; Rajpara A; Hocker TLH
J Am Acad Dermatol; 2021 Mar; 84(3):833-835. PubMed ID: 33022309
[No Abstract] [Full Text] [Related]
10. Melanoma and Mohs' micrographic surgery.
Grevey SC; Zax RH; McCall MW
Adv Dermatol; 1995; 10():175-98; discussion 199. PubMed ID: 7794671
[No Abstract] [Full Text] [Related]
11. Subungual malignant melanoma.
Martin DE; English JC; Goitz RJ
J Hand Surg Am; 2011 Apr; 36(4):704-7. PubMed ID: 21277700
[No Abstract] [Full Text] [Related]
12. Re: Determinants of BRAF mutations in primary melanomas.
Purdue MP
J Natl Cancer Inst; 2005 Mar; 97(5):401-2; author reply 402. PubMed ID: 15741578
[No Abstract] [Full Text] [Related]
13. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
[TBL] [Abstract][Full Text] [Related]
14. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
15. Progression of NRAS and BRAF mutations in cutaneous melanoma.
Rosso R; Romagosa Y; Kirsner RS
J Invest Dermatol; 2009 Jun; 129(6):1318. PubMed ID: 19434085
[No Abstract] [Full Text] [Related]
16. A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF inhibitor therapy for metastatic melanoma.
Fathi R; Kamalpour L; Gammon B; Tung R
Dermatol Surg; 2013 Feb; 39(2):341-4. PubMed ID: 23227856
[No Abstract] [Full Text] [Related]
17. Mohs surgery for melanoma in situ: how we do it.
Cherpelis BS; Glass LF; Ladd S; Fenske NA
J Drugs Dermatol; 2010 Jul; 9(7):786-8. PubMed ID: 20677533
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAF(V600E) Melanoma.
Wieder SY; Serasinghe MN; Sung JC; Choi DC; Birge MB; Yao JL; Bernstein E; Celebi JT; Chipuk JE
J Invest Dermatol; 2015 Oct; 135(10):2544-2547. PubMed ID: 26032958
[No Abstract] [Full Text] [Related]
19. Molecular mechanisms of melanoma.
Pickert A
Cutis; 2012 Mar; 89(3):E1-4. PubMed ID: 23961517
[No Abstract] [Full Text] [Related]
20. Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.
Hofman V; Ilie M; Long-Mira E; Giacchero D; Butori C; Dadone B; Selva E; Tanga V; Passeron T; Poissonnet G; Emile JF; Lacour JP; Bahadoran P; Hofman P
J Invest Dermatol; 2013 May; 133(5):1378-81. PubMed ID: 23303445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
